Documents
Resources
Learning Center
Upload
Plans & pricing Sign in
Sign Out
Your Federal Quarterly Tax Payments are due April 15th Get Help Now >>

Med BioGene Inc. (MBI) - Product Pipeline Analysis

VIEWS: 27 PAGES: 30

Med BioGene Inc. (MBI) - Product Pipeline Analysis Summary This report is a source for data, analysis and actionable intelligence on the Med BioGene Inc. portfolio of pipeline products. The report provides detailed analysis on each pipeline product with information on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date. Each pipeline product is profiled to cover information on product description, function, technology, indication, and application. The report is also supplemented with a detailed company profile and information on clinical trials, wherever applicable. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts. Scope - Detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments. - Detailed coverage on all the pipeline products, by equipment type, by therapy area, by development stage, and by trial phase. - Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date. - Profile of each pipeline product with additional information on product description, function, technology, indication(s), and application. - Data on relevant clinical trials and product patent details, wherever applicable. - Information on clinical trial, wherever applicable, is supplemented with information on trial phase, trial status, trial objective, trial design, target patients, unique physician identifier, primary point, secondary point, acronym, participants inclusion, participants exclusion, interventions, trial results, trial start date, trial end date, study type, trial site, trial funding, age eligibility, and gender eligibility. Reasons to

More Info
									                                        Med BioGene Inc. (MBI) - Product Pipeline Analysis

     Reference Code: GDMEPH22296PD                                                                                                Publication Date: NOV 2010



     Company Snapshot                                                         Company Overview
     Key Information
                                                                              Med BioGene Inc. (MBI) is a developmental stage life sciences company
     Med BioGene Inc., Key Facts                                              which is focused on the development genomic biomarker based clinical
                                                                              laboratory tests for early diagnosis and screening for cancer and
     Web Address                            www.medbiogene.com
                                                                              cardiovascular disease. the company's lead product is LungExpress Dx, a
     Industry                               Pharmaceuticals and Healthcare-   test for early-stage non-small-cell lung cancer. It analyses the genetic
     Source:Primary / Secondary Research                                      profile of the patient's tumour cell to to assist in diagnosis and prognosis.
     GlobalData                                                               The company’s extensive Research and Development (R&D) facilities &
                                                                              office are on the campus of the University of British Colombia. It is
                                                                              headquartered in Vancouver, Canada



     Med BioGene Inc. Pipeline Products

      Med BioGene Inc. Key Pipeline Products by Equipment                     Med BioGene Inc. Key Pipeline Products by Therapy Area
      Type
     Equipment Type                         No of Products                    Therapy Area                                             No of Products
     Immuno Chemistry                              1                          Cardiovascular diseases                                         1
     Genetic Testing                               1                          Hodgkin lymphoma, Non hodgkin b-cell lymphoma                    1
                                                                              Lung cancer                                                      1
     Source: Primary / Secondary Research                                     Source: Primary / Secondary Research
     GlobalData                                                               GlobalData




     Med BioGene Inc. Key Pipeline Products by Development Stage

     Developmental Stage                                                                                         No of Products
     Clinicals                                                                                                          2
     Pre-Clinicals                                                                                                     -
     Early development                                                                                                 1
     No Specific Phase                                                                                                 1
     Source: Primary / Secondary Research
     GlobalData
     Note : (-) indicates 'Not Available'



     Med BioGene Inc. Key Pipeline Products by Trial Phase

     Trial Phase                                                                                                 No of Products
     Phase IV                                                                                                          -
     Phase III                                                                                                         -
     Phase II                                                                                                          1
     Phase I                                                                                                           -
     Source: Primary / Secondary Research
     GlobalData
     Note : (-) indicates 'Not Available'




Med BioGene Inc. (MBI) - Product Pipeline Analysis                                                                                 Reference Code: GDMEPH22296PD

Source : www.globalcompanyintelligence.com                                                                                                                     Page 1
     Table of Contents
     Table of Contents................................................................................................................................................................................................................................................................... 2
     List of Tables .......................................................................................................................................................................................................................................................................... 3
     List of Figures......................................................................................................................................................................................................................................................................... 3
     Med BioGene Inc. - Business Description.............................................................................................................................................................................................................................. 4
     Key Facts ............................................................................................................................................................................................................................................................................... 5
     Med BioGene Inc. - Major Products and Services ................................................................................................................................................................................................................. 6
           Med BioGene Inc. Pipeline Products by Equipment Type ............................................................................................................................................................................................... 7
           Med BioGene Inc. Pipeline Products by Development Stage ......................................................................................................................................................................................... 9
           Med BioGene Inc. Pipeline Products by Therapy Area ................................................................................................................................................................................................. 11
           Med BioGene Inc. Pipeline Products by Trial Phase ..................................................................................................................................................................................................... 13
           Med BioGene Inc. Pipeline Products by Milestone Summary ....................................................................................................................................................................................... 15
           Cardiovascular disease diagnostic test ......................................................................................................................................................................................................................... 17
                 Product Status......................................................................................................................................................................................................................................................... 17
                 Product Description ................................................................................................................................................................................................................................................. 17
                 Product Institution Details ....................................................................................................................................................................................................................................... 17
           LungExpress Dx ............................................................................................................................................................................................................................................................ 17
                 Product Status......................................................................................................................................................................................................................................................... 17
                 Product Description ................................................................................................................................................................................................................................................. 17
                 Product Milestone ...............................................................................................................................................................................................................
								
To top